Published in Exp Clin Endocrinol Diabetes on January 01, 1998
Update multiple endocrine neoplasia type 2. Fam Cancer (2010) 1.06
Routine calcitonin determination in thyroid nodules--an effective approach? Exp Clin Endocrinol Diabetes (1998) 0.77
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62
Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int (1998) 2.45
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30
Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol (1984) 2.22
Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. J Nucl Med (1993) 2.20
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1997) 2.18
Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18
Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet (2000) 1.98
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res (1998) 1.77
Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res (2000) 1.66
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Anthroposophic therapies in chronic disease: the Anthroposophic Medicine Outcomes Study (AMOS). Eur J Med Res (2004) 1.45
Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases. Clin Chem (1996) 1.45
Response to methimazole in Graves' disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) (1995) 1.44
Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes (1997) 1.42
Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab (2001) 1.42
DNA uptake during genetic transformation and the growing zone of the cell envelope. Proc Natl Acad Sci U S A (1971) 1.41
[Thoracic pain in a power athlete]. Internist (Berl) (1997) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation (1997) 1.38
[Androgens and bone metabolism. Significance in osteoporosis in man and woman]. Dtsch Med Wochenschr (1992) 1.38
Binding of the competence factor to receptors in the spheroplast membrane of pneumococci. Biochem Biophys Res Commun (1970) 1.37
The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors (1999) 1.33
Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32
A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner (1990) 1.30
The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch Intern Med (1992) 1.29
Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract (2001) 1.28
Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest (1995) 1.27
Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf) (1996) 1.23
On the phylogenetic position of the pre-Neandertal specimen from Reilingen, Germany. J Hum Evol (1998) 1.21
Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes (2001) 1.20
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer (2001) 1.20
Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab (1998) 1.17
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology (1996) 1.17
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab (1998) 1.16
Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes (1989) 1.16
Quality of life and vertebral osteoporosis. Osteoporos Int (1992) 1.15
Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med (2001) 1.15
Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care (1998) 1.15
Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis. J Bone Miner Res (1997) 1.13
Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. J Nucl Med (1999) 1.13
Chemotactic response of osteoblastlike cells to transforming growth factor beta. J Bone Miner Res (1990) 1.13
Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology (1990) 1.12
Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin. Eur J Nucl Med (1998) 1.12
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer (1995) 1.10
Anthroposophic vs. conventional therapy for chronic low back pain: a prospective comparative study. Eur J Med Res (2007) 1.09
Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes (1993) 1.09
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol (2006) 1.08
[Experiences with nifedipine in the treatment of acute hypertension in childhood]. Monatsschr Kinderheilkd (1985) 1.07
Changes in bone turnover induced by aerobic and anaerobic exercise in young males. J Bone Miner Res (1998) 1.06
The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost (1997) 1.05
sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells. J Clin Invest (1987) 1.04
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene (1999) 1.03
Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology (1996) 1.02
Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab (2010) 1.00
Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: one or two receptors? EMBO J (1987) 1.00
Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine. Am J Nephrol (1986) 1.00
Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res (1999) 0.99
Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. Eur J Endocrinol (1996) 0.99
Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res (1997) 0.99
Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes (1996) 0.99
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol (1994) 0.98
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1998) 0.98
Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results. Cancer (1993) 0.97
Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery (2001) 0.97
Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes (1991) 0.97
Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol (1994) 0.97
Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab (1995) 0.96
Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study. J Cancer Res Clin Oncol (1990) 0.96
Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab (1993) 0.95
Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab (1998) 0.95
Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid (1992) 0.95
The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol (Copenh) (1975) 0.95
Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest (1998) 0.95
Association of transforming growth factor-beta1 (TGFbeta1) T29 --> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women. Calcif Tissue Int (2001) 0.95
17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic Res Commun (1990) 0.94
Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes (2004) 0.94
A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner (1988) 0.93
Endothelin-1 is a potent regulator of human bone cell metabolism in vitro. Calcif Tissue Int (1997) 0.92
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) (1995) 0.92
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res (1996) 0.92
Increased prevalence of colonic adenomas in patients with acromegaly. Eur J Endocrinol (1994) 0.92
Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis. Hum Genet (1992) 0.92
Persistent inhibition of gastric secretion by an intravenous 12-hour infusion of calcitonin in normals, peptic ulcer and high risk patients. Digestion (1974) 0.92
Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab (1998) 0.92
Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations. Calcif Tissue Int (1997) 0.91
Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. Cardiovasc Res (1998) 0.91
Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J Bone Miner Res (1998) 0.90
Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. Gut (1999) 0.90
[Paget's disease of bone: ultrastructure and cytogenesis of osteoclasts (author's transl)]. Virchows Arch A Pathol Anat Histol (1977) 0.90